How much is patent protection threatened by drug costs?

Author： Loff Bebe  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.9, 2004-09, pp. : 1863-1865

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug patent expiry reduces costs by prompting a switch to generic drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 492, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

How Much Is Too Much?

By COLEMAN WILLIAM P.  

Dermatologic Surgery, Vol. 22, Iss. 11, 1996-11 ,pp. : 978-978

Elsevier

Access to resources Recommend Favorite

How Much Missing May Be Too Much in Clinical Trials of Neuropharmacological Drug Products

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 3, 2014-12 ,pp. : 125-134

Bentham Science Publishers

Access to resources Recommend Favorite

How much should go into the UK cancer drug fund?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 606, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

How Much Gets there and What Does it Do?: The Need for Better Pharmacokinetic and Pharmacodynamic Endpoints in Contemporary Drug Discovery and Development

By  

Current Pharmaceutical Design, Vol. 9, Iss. 11, 2003-04 ,pp. : 891-902

Bentham Science Publishers

Access to resources Recommend Favorite